ARTICLE | Financial News
Anchiano prices $30.5M NASDAQ offering
February 15, 2019 6:38 PM UTC
Anchiano Therapeutics Ltd. (Tel Aviv:ANCN; NASDAQ:ANCN) raised $30.5 million via a listing of ADSs on NASDAQ.
On Feb. 12, the gene therapy company priced 2.6 million ADSs at $11.50, giving it a valuation of $78.5 million. Anchiano had hoped to sell 2.4 million ADSs, each of which is worth five ordinary shares...